Stay updated on Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.
Latest updates to the Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page
- Check5 days agoChange DetectedThe website has updated the intervention details to include a verified status by Genor Biopharma Co., Ltd. and the contact information for the principal investigator, Yuxian Bai, while removing previous version details and contact formatting.SummaryDifference2%
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check41 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with a reference to the Contacts and Locations section.SummaryDifference2%
- Check55 days agoChange DetectedThe website has added new content, while several links and detailed options related to downloads and study data fields have been removed.SummaryDifference4%
- Check69 days agoChange DetectedThe website has been updated to version 2.12.2, introducing new features such as a menu for Participant Group/Arm and Intervention/Treatment, along with various download options for study data.SummaryDifference4%
- Check77 days agoChange DetectedThe website has been updated to Revision v2.12.1, with the removal of several topics including Immunologic Factors and Physiological Effects of Drugs from the previous version v2.12.0.SummaryDifference0.4%
Stay in the know with updates to Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Geptanolimab+Fruquintinib in Metastatic Colorectal Cancer Clinical Trial page.